Enzymatic syntheses of dopamine glycosides

Enzyme and Microbial Technology

Volumn 44, Issue 1, 2009, Pages 33-39

  Sivakumar, Ramaiah ^a   Divakar, Soundar ^a  

^a CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

Author keywords

Glucosidase; ACE inhibition; Antioxidant activity; Dopamine glycosides; Enzymatic synthesis; Glucoamylase

Indexed keywords

BRAIN; GLUCOSE; SUGARS; SYNTHESIS (CHEMICAL);

ACE INHIBITION; ANTIOXIDANT ACTIVITY; DOPAMINE GLYCOSIDES; ENZYMATIC SYNTHESIS; GLUCOAMYLASE;

ENZYMES;

3 HYDROXY 4 O (6 DEXTRO GALACTOPYRANOSYL)PHENYLETHYLAMINE; 3 HYDROXY 4 O (ALPHA DEXTRO GALACTOPYRANOSYL)PHENYLETHYLAMINE; 3 HYDROXY 4 O (ALPHA DEXTRO GLUCOPYRANOSYL)PHENYLETHYLAMINE; 3 HYDROXY 4 O (ALPHA DEXTRO MANNOPYRANOSYL)PHENYLETHYLAMINE; 3 HYDROXY 4 O (BETA DEXTRO GALACTOPYRANOSYL)PHENYLETHYLAMINE; 3 HYDROXY 4 O (BETA DEXTRO GLUCOPYRANOSYL)PHENYLETHYLAMINE; 3 HYDROXY 4 O (BETA DEXTRO MANNOPYRANOSYL)PHENYLETHYLAMINE; 4 HYDROXY 3 O (ALPHA DEXTRO GALACTOPYRANOSYL)PHENYLETHYLAMINE; 4 HYDROXY 3 O (ALPHA DEXTRO MANNOPYRANOSYL)PHENYLETHYLAMINE; 4 HYDROXY 3 O (BETA DEXTRO GLUCOPYRANOSYL)PHENYLETHYLAMINE; BETA GLUCOSIDASE; BUFFER; DOPAMINE; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLYCOSIDE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; DRUG SYNTHESIS; ENZYME SYNTHESIS; NONHUMAN; PH MEASUREMENT; RHIZOPUS; ULTRAVIOLET SPECTROSCOPY;

RHIZOPUS;

EID: 56549092036     PISSN: 01410229     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.enzmictec.2008.09.014     Document Type: Article

References (30)

1. Geng X., Tian X., Tu P., and Pu X. Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease. Eur J Pharmacol 564 (2007) 66-74
2. Geng X., Song L., Pu X., and Tu P. Neuroprotective effects of phenylethanoid glycosides from Cistanches salsa against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 Mice. Biol Pharm Bull 27 6 (2004) 797-801
3. Pardridge W.M. Targeting neurotherapeutic agents through the blood-brain barrier. Arch Neurol 59 (2002) 35-40
4. Audus K.L., Chikhale P.J., Miller W.D., Thompson S.E., and Borchardt R.T. Brain uptake of drugs: the influence of chemicals and biological factors. Adv Drug Res 23 (1992) 1-64
5. Madrid Y., Langer L.F., Brem H., and Langer R. New directions in the delivery of drugs and other substances to the central nervous system. Adv Pharmacol 22 (1991) 299-324
6. Mueckler M. Facilitative glucose transporters. Eur J Biochem 219 (1994) 713-725
7. Fernandez C., Nieto O., Rivas E., Montenegro G., Fontenla J.A., and Fernandez-Mayoralas A. Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents. Carbohydr Res 327 (2000) 353-365
8. Dalpiaz A., Filosa R., de Caprariis P., Conte G., Bortolotti F., Biondi C., et al. Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate. Int J Pharm 336 (2007) 133-139
9. Fernandez C., Nieto O., Fontenla J.A., Rivas E., de Ceballos M.L., and Fernandez-Mayoralas A. Synthesis of glycosyl derivatives as dopamine prodrugs: interaction with glucose carrier GLUT-1. Org Biomol Chem 1 (2003) 767-771
10. Suzuki Y., Ki Y.H., Uchida K., and Takami M. Enzymatic synthesis of glucosylated and phosphatidylated biologically active compounds. J Appl Glycosci 43 (1996) 273-282
11. Vic G., and Thomas D. Enzyme-catalyzed synthesis of alkyl-β-d-glucosides in organic media. Tetrahedron Lett 33 (1992) 4567-4570
12. Vijayakumar G.R., and Divakar S. Amyloglucosidase catalyzed synthesis of eugenyl and curcuminyl glycosides. Biotechnol Lett 29 (2007) 575-584
13. Sivakumar R., and Divakar S. Glycosylation of vanillin by amyloglucosidase in organic media. Tetrahedron Lett 47 (2006) 695-699
14. Gow-Chin Y., and Chiu-Luan H. Antioxidant effects of dopamine and related compounds. Biosci Biotechnol Biochem 61 (1997) 1646-1649
15. Marin J., Marin E., Gutierrez-Iniguez M.A., Avendano C., and Rodriguez-Martinez M.A. Mechanisms involved in the hemodynamic alterations in congestive heart failure as a basis for a rational pharmacological treatment. Pharmacol Ther 88 (2000) 15-31
16. Hestrin S., Feingold D.S., and Schramm M. Hexoside hydrolases. In: Colowick S.P., and Kaplan N.O. (Eds). Methods in enzymology vol. 1 (1955), Academic Press, Inc., New York, NY 234-240
17. Won K., Kim S., Kim K.J., Park H.W., and Moon S.J. Optimization of lipase entrapment in Ca alginate gel beads. Process Biochem 40 (2005) 2149-2154
18. Colowick S.P., and Kaplan N.O. Immobilized enzymes. In: Mosbach K. (Ed). Methods in enzymology vol. 44 (1976), Academic Press, Inc., New York, NY 101-104
19. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randal R.J. Protein measurement with Folin phenol reagent. J Biol Chem 193 (1951) 265-275
20. Sumner J.B., and Sisler E.B. A simple method for blood sugar. Arch Biochem 4 (1944) 333-336
21. Cushman D.W., and Cheung H.S. Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Chem Pharmacol 20 (1971) 1637-1638
22. Lohith K., Vijayakumar G.R., Somashekar B.R., Sivakumar R., and Divakar S. Glycosides and amino acyl esters of carbohydrates as potent inhibitors of angiotensin converting enzyme. Eur J Med Chem 41 (2006) 1059-1072
23. Moon J.H., and Tearo J. Antioxidant activity of caffeic acid and dihydro caffeic acid in lard and luman low density lipoprotein. J Agric Food Chem 48 (1998) 5062-5065
24. Ponrasu T., Einstein Charles R., Sivakumar R., and Divakar S. Syntheses of α-tocopheryl glycosides by glucosidases. Biotechnol Lett 30 (2008) 1431-1439
25. Lohith K., and Divakar S. Lipase-catalysed synthesis of l-phenylalanyl-d-glucose. J Biotechnol 117 (2005) 49-56
26. Davis B.G., and Boyer V. Biocatalysis and enzymes in organic synthesis. Nat Prod Rep 18 (2001) 618-640
27. Okahata Y., and Mori T. Transglycosylation catalysed by a lipid-coated β-d-galactosidae in a two-phase aqueous organic system. J Mol Catal B Enz 5 (1998) 119-123
28. Mori T., and Okahata Y. Effective biocatalytic transglycosylation in a supercritical fluid using a lipid-coated enzyme. Chem Commun 20 (1998) 2215-2216
29. Michaud A., Williams T.A., Chauvet M.T., and Corvol P. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I. Mol Pharmacol 51 (1997) 1070-1076
30. De-Lima D.P. Synthesis of angiotensin-converting enzyme (ACE) inhibitors: an important class of antihypertensive drugs. Quim Nova 22 (1999) 375-381